What Raises Homocysteine
| Cause | Mechanism |
|---|---|
| Vitamin B12 deficiency | Impairs homocysteine breakdown |
| Folate deficiency | Same pathway affected |
| Vitamin B6 deficiency | Alternative pathway affected |
| Kidney disease | Reduced clearance |
| Genetic (MTHFR mutation) | Reduced enzyme efficiency: common but usually mild effect |
| Smoking, high coffee intake | Modest elevation |
Homocysteine and Cardiovascular Risk
High homocysteine is associated with increased risk of heart attack, stroke, and blood clots, likely through effects on blood vessel lining and clotting. However, clinical trials lowering homocysteine with B vitamins have not consistently reduced cardiovascular events, so it remains a marker rather than a definitively modifiable risk factor.How to Lower Homocysteine
- Correct any B12, folate, or B6 deficiency
- Reduce coffee intake if very high
- Stop smoking
- Folic acid + B12 + B6 supplementation can lower levels by 25-30%, though cardiovascular benefit is unproven
References
The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.
- Hyperhomocysteinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK554408
Related reading
- Heart Health Blood Tests: Complete GuideWhich blood tests assess heart health? Complete guide to cholesterol…
- Guide to Vitamin Deficiency Blood TestsWhich blood tests detect vitamin deficiencies? Learn how to test for…
- Vitamin & Mineral DeficiencyWhich blood tests check for vitamin deficiencies? Learn about Vitamin…
- Low-Dose Aspirin: Who Should Take It and WhyShould you take low-dose aspirin for heart disease prevention?…
- Child Health Blood Tests: A Parent's GuideWhat blood tests are recommended for children? A guide to common…
- Hypertension: Understanding and Managing High Blood PressuHypertension affects 1 in 4 adults and is the leading cause of stroke…
Why lowering homocysteine has not translated into fewer heart attacks
Homocysteine is reliably associated with cardiovascular disease in observational studies, which made it an attractive treatment target. However, large randomised trials of B vitamins that successfully lowered homocysteine did not produce the expected reduction in heart attacks or cardiovascular death. The most likely explanation is that raised homocysteine is a marker of risk rather than a cause of it, travelling alongside kidney impairment, poor nutrition and other factors that carry the real risk. This is why routine homocysteine testing is not recommended for cardiovascular risk assessment in the general population, and why a raised level is not by itself a reason to start supplements.
Where the test genuinely helps
- Suspected B12 deficiency with a borderline B12 level, where homocysteine and methylmalonic acid both rise and help confirm true tissue deficiency.
- Distinguishing B12 from folate deficiency: homocysteine rises in both, but methylmalonic acid rises only in B12 deficiency.
- Suspected homocystinuria, an inherited metabolic disorder presenting with lens dislocation, skeletal abnormalities, learning difficulty and early thrombosis, where levels are extremely high.
- Unexplained venous thrombosis in a young person, as part of a broader assessment.
Sample handling changes the result
Homocysteine continues to be released from red cells after the blood is drawn, so a sample left at room temperature gives a falsely high result. Samples need to be placed on ice or centrifuged promptly, typically within an hour. An isolated raised homocysteine from a sample that sat in a warm room is a common and avoidable false positive, and is worth asking about before pursuing an unexpected result. Kidney impairment is the other frequent explanation, since homocysteine is cleared renally and rises as eGFR falls.